Published in Open Microbiol J on November 18, 2011
Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates. ACS Chem Biol (2013) 0.84
C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W. BMC Microbiol (2013) 0.83
Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans. Infect Immun (2015) 0.80
Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. Biomed Res Int (2015) 0.78
Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms. PLoS One (2015) 0.77
Dosage and Dose Schedule Screening of Drug Combinations in Agent-Based Models Reveals Hidden Synergies. Front Physiol (2016) 0.76
Sociomicrobiome of wood decay in a tropical rain forest: unraveling complexity. Springerplus (2013) 0.76
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol (2001) 4.63
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev (2003) 4.07
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol (2002) 3.87
The distinct morphogenic states of Candida albicans. Trends Microbiol (2004) 3.86
Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol (2007) 3.43
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis (2004) 3.25
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol (1994) 3.23
Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med (1989) 2.97
Candida infections: an overview. Crit Rev Microbiol (1987) 2.38
Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses (2005) 1.96
Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med (2009) 1.93
Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol (1993) 1.92
Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol Microbiol (2008) 1.89
Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol (1995) 1.88
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem (2005) 1.77
Candida albicans proteinases: resolving the mystery of a gene family. Microbiology (2001) 1.74
Candida albicans proteinases and host/pathogen interactions. Cell Microbiol (2004) 1.73
Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc Natl Acad Sci U S A (2008) 1.70
Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol (2008) 1.61
Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother (2006) 1.60
Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology (2008) 1.52
Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol (2006) 1.51
Candida and oral candidosis: a review. Crit Rev Oral Biol Med (1994) 1.48
Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot Cell (2005) 1.45
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm (2009) 1.44
Farnesol-induced apoptosis in Candida albicans. Antimicrob Agents Chemother (2009) 1.39
Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett (2009) 1.31
Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med (2005) 1.30
Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob Agents Chemother (2004) 1.21
Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microbiol (2005) 1.18
Adherence mechanisms in human pathogenic fungi. Med Mycol (2008) 1.16
Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother (2003) 1.06
Effects of farnesol on the physical properties of DMPC membranes. Biochim Biophys Acta (2005) 1.06
Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology (2004) 1.01
Secretion of E,E-farnesol and biofilm formation in eight different Candida species. Antimicrob Agents Chemother (2008) 0.99
Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. Yeast (2007) 0.91
Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Mycoses (2007) 0.89
Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol (1995) 0.88
Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro. Mycoses (2008) 0.86
In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. Yeast (2006) 0.84
The quorum-sensing molecule E,E-farnesol--its variable secretion and its impact on the growth and metabolism of Candida species. Yeast (2010) 0.83
Farnesol restores wild-type colony morphology to 96% of Candida albicans colony morphology variants recovered following treatment with mutagens. Genome (2006) 0.83
Farnesol and geranylgeraniol modulate the structural properties of phosphatidylethanolamine model membranes. Mol Membr Biol (2005) 0.83
Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form. J Appl Microbiol (2008) 0.80
Mycology in oral pathology. Acta Stomatol Belg (1997) 0.79
Farnesol modulates membrane currents in human retinal glial cells. J Neurosci Res (2000) 0.77
The effect of farnesol on amino acid incorporation by a wild-type and cell-wall variant strain of Candida albicans. Can J Microbiol (2005) 0.77
The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res (2007) 1.77
Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. Res Microbiol (2005) 1.38
Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect Immun (2006) 1.33
New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol (2005) 1.26
In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun (2004) 1.26
Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol (2007) 1.18
Electrically conductive biodegradable polymer composite for nerve regeneration: electricity-stimulated neurite outgrowth and axon regeneration. Artif Organs (2007) 1.17
Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun (2010) 1.09
A novel electrically conductive and biodegradable composite made of polypyrrole nanoparticles and polylactide. Biomaterials (2004) 1.03
Whole cigarette smoke increased the expression of TLRs, HBDs, and proinflammory cytokines by human gingival epithelial cells through different signaling pathways. PLoS One (2012) 1.00
UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53. Biochem J (2002) 1.00
Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. Microbiology (2011) 0.97
Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol (2004) 0.95
SYBR green as a fluorescent probe to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can J Microbiol (2011) 0.94
Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cell Microbiol (2004) 0.93
A novel collagen/hydroxyapatite/poly(lactide-co-ε-caprolactone) biodegradable and bioactive 3D porous scaffold for bone regeneration. J Biomed Mater Res A (2011) 0.92
In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes. J Biomed Mater Res A (2004) 0.91
Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J Med Microbiol (2011) 0.91
Accelerated osteoblast mineralization on a conductive substrate by multiple electrical stimulation. J Bone Miner Metab (2011) 0.90
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J Cell Physiol (2007) 0.90
Candida famata modulates toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol (2010) 0.89
Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog (2011) 0.89
Wound healing activity of the human antimicrobial peptide LL37. Peptides (2011) 0.89
Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human beta-defensin 2 production. Cytokine (2009) 0.89
Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold. Biomed Mater (2008) 0.88
Increased number of glutamine repeats in the C-terminal of Candida albicans Rlm1p enhances the resistance to stress agents. Antonie Van Leeuwenhoek (2009) 0.88
Kinetics of the breakdown of cross-linked soy protein films for drug delivery. Biomaterials (2008) 0.87
Microfluidic assembly of multistage porous silicon-lipid vesicles for controlled drug release. Lab Chip (2014) 0.87
Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells. J Cell Physiol (2005) 0.86
Removal of triphenylmethane dyes by bacterial consortium. ScientificWorldJournal (2012) 0.86
Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents. Clin Vaccine Immunol (2008) 0.86
Effects of whole cigarette smoke on human gingival fibroblast adhesion, growth, and migration. J Toxicol Environ Health A (2011) 0.86
Engineering bone tissue using human dental pulp stem cells and an osteogenic collagen-hydroxyapatite-poly (L-lactide-co-ε-caprolactone) scaffold. J Biomater Appl (2013) 0.85
Gingival and dermal fibroblasts produce interleukin-1 beta converting enzyme and interleukin-1 beta but not interleukin-18 even after stimulation with lipopolysaccharide. J Cell Physiol (2004) 0.85
Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection. PLoS One (2010) 0.85
In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. Yeast (2006) 0.84
Modulation of poly-N-acetylglucosamine accumulation within mature Staphylococcus epidermidis biofilms grown in excess glucose. Microbiol Immunol (2011) 0.83
Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites. Immunology (2005) 0.83
Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. Arch Oral Biol (2010) 0.83
Increased T-cell survival by structural bronchial cells derived from asthmatic subjects cultured in an engineered human mucosa. J Allergy Clin Immunol (2008) 0.82
Polymeric nanogels as vaccine delivery systems. Nanomedicine (2012) 0.82
In vitro analyses of tissue structure and interleukin-1beta expression and production by human oral mucosa in response to Candida albicans infections. Cytokine (2004) 0.82
Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines. Mediators Inflamm (2010) 0.82
Optimization of an automatic counting system for the quantification of Staphylococcus epidermidis cells in biofilms. J Basic Microbiol (2013) 0.82
Electrical stimulation enhances viability of human cutaneous fibroblasts on conductive biodegradable substrates. J Biomed Mater Res A (2008) 0.82
Survival of Vibrio alginolyticus in seawater and retention of virulence of its starved cells. Mar Environ Res (2007) 0.82
Heparin dopant increases the electrical stability, cell adhesion, and growth of conducting polypyrrole/poly(L,L-lactide) composites. J Biomed Mater Res A (2008) 0.82
Mucosal and systemic T cell response in mice intragastrically infected with Neospora caninum tachyzoites. Vet Res (2013) 0.81
Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. Indian J Dent Res (2009) 0.81
The regulation of cell functions electrically using biodegradable polypyrrole-polylactide conductors. Biomaterials (2008) 0.81
Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Med Mycol (2010) 0.81
Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis. Glycobiology (2010) 0.80
Characterization and evaluation of whey protein-based biofilms as substrates for in vitro cell cultures. Biomaterials (2005) 0.80
Plasmacytoid and conventional dendritic cells are early producers of IL-12 in Neospora caninum-infected mice. Immunol Cell Biol (2009) 0.80
Immune response in the adipose tissue of lean mice infected with the protozoan parasite Neospora caninum. Immunology (2015) 0.79
Quantification of the CBD-FITC conjugates surface coating on cellulose fibres. BMC Biotechnol (2008) 0.79
Dormancy within Staphylococcus epidermidis biofilms: a transcriptomic analysis by RNA-seq. Appl Microbiol Biotechnol (2014) 0.79
Electrical stimulation modulates osteoblast proliferation and bone protein production through heparin-bioactivated conductive scaffolds. Bioelectromagnetics (2012) 0.79
Hydroxyapatite bioactivated bacterial cellulose promotes osteoblast growth and the formation of bone nodules. AMB Express (2012) 0.78
Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis. Hum Mol Genet (2013) 0.78
Tissue structure, and IL-1beta, IL-8, and TNF-alpha secretions after contact by engineered human oral mucosa with dentifrices. J Clin Periodontol (2002) 0.78
The sunscreen agent 2-phenylbenzimidazole-5-sulfonic acid photosensitizes the formation of oxidized guanines in cellulo after UV-A or UV-B exposure. J Invest Dermatol (2010) 0.78
Confinement effects on drugs in thermally hydrocarbonized porous silicon. Langmuir (2014) 0.77
Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood. Pathog Dis (2014) 0.77
Poly(methyl vinyl ether-alt-maleic acid)-functionalized porous silicon nanoparticles for enhanced stability and cellular internalization. Macromol Rapid Commun (2014) 0.77
Monoclonal antibody raised against PNAG has variable effects on static S. epidermidis biofilm accumulation in vitro. Int J Biol Sci (2013) 0.77
Ptaquiloside-induced, B-cell lymphoproliferative and early-stage urothelial lesions in mice. Toxicon (2011) 0.77
Bacterial cellulose: long-term biocompatibility studies. J Biomater Sci Polym Ed (2012) 0.77
Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery. Nanoscale (2015) 0.76
Bioactivating electrically conducting polypyrrole with fibronectin and bovine serum albumin. J Biomed Mater Res A (2010) 0.76
Proteomic profile of dormancy within Staphylococcus epidermidis biofilms using iTRAQ and label-free strategies. Appl Microbiol Biotechnol (2015) 0.76
Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells. FEMS Immunol Med Microbiol (2011) 0.76
Phenotypic stress response of Pseudomonas aeruginosa following culture in water microcosms. J Water Health (2012) 0.76
Host defense mechanisms in invasive candidiasis originating in the GI tract. Expert Rev Anti Infect Ther (2008) 0.76
Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis. Med Sci Monit (2004) 0.76
Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract. Immunology (2014) 0.75
Cytokine release and cytotoxicity in human keratinocytes induced by polycyclic aromatic hydrocarbons (1-methylpyrene and perylene). J Toxicol Environ Health A (2010) 0.75
Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system. Int J Pharm (2010) 0.75
Immunostimulatory properties of coffee mannans. Mol Nutr Food Res (2009) 0.75
Proteome signatures--how are they obtained and what do they teach us? Appl Microbiol Biotechnol (2015) 0.75
Unraveling the uptake mechanisms of mannan nanogel in bone-marrow-derived macrophages. Macromol Biosci (2012) 0.75
Quantitative high-throughput measurement of gene expression with sub-zeptomole sensitivity by capillary electrophoresis. Anal Biochem (2005) 0.75
Production of biocompatible and antimicrobial bacterial cellulose polymers functionalized by RGDC grafting groups and gentamicin. ACS Appl Mater Interfaces (2014) 0.75
A medical device for prefabrication of large bone grafts in modern medicine. Med Hypotheses (2010) 0.75
Production and in vitro evaluation of soy protein-based biofilms as a support for human keratinocyte and fibroblast culture. Tissue Eng Part A (2009) 0.75
Self-assembled mannan nanogel: cytocompatibility and cell localization. J Biomed Nanotechnol (2012) 0.75
Analysis of explanted Latecba modular stent-grafts deployed transrenally to repair AAAs with short necks in 29 dogs. Artif Cells Blood Substit Immobil Biotechnol (2009) 0.75
Conductive Polymer Waving in Liquid Nitrogen. ACS Nano (2017) 0.75
CD36(+)-DENDRITIC EPIDERMAL CELLS: A PUTATIVE ACTOR IN THE CUTANEOUS IMMUNE SYSTEM. Cell Transplant (1994) 0.75
Persistent type II endoleak unrelated to an Anaconda aortic stent graft fulfilling the 3Bs requirements of biofunctionality, biodurability, and biocompatibility. J Long Term Eff Med Implants (2008) 0.75
Self-assembled dextrin nanogel as protein carrier: controlled release and biological activity of IL-10. Biotechnol Bioeng (2011) 0.75
Effect of hydroxamic acid-based matrix metalloproteinase inhibitors on human gingival cells and Porphyromonas gingivalis. J Periodontol (2003) 0.75
Purification, structure and immunobiological activity of an arabinan-rich pectic polysaccharide from the cell walls of Prunus dulcis seeds. Carbohydr Res (2004) 0.75
Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer. Invest New Drugs (2002) 0.75